FDA Adverse Event Malfunction Summary report: N

CAPIOX FX OXYGENATOR

MDR report key: 7393255 · Received April 3, 2018

Report

Report Number
9681834-2018-00040
Event Type
Malfunction
Date Received
April 3, 2018
Date of Event
March 14, 2018
Report Date
April 3, 2018
Manufacturer
TERUMO CORPORATION, ASHITAKA
Product Code
DTZ
PMA / PMN Number
K071494
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

D6: IMPLANTED DATE: DEVICE WAS NOT IMPLANTED D7: EXPLANTED DATE: DEVICE WAS NOT EXPLANTED G5: 510K - K130520 THE ACTUAL DEVICE WAS RETURNED FOR EVALUATION. VISUAL INSPECTION REVEALED THE SAMPLING LINE TUBE HAD BEEN FLATTENED. A REVIEW OF THE DEVICE HISTORY RECORD AND SHIPPING INSPECTION RECORD OF THE INVOLVED PRODUCT CODE/LOT NUMBER COMBINATION REVEALED THERE WERE NO INDICATION OF PRODUCTION RELATED ANOMALIES. HOWEVER, IT WAS FOUND THERE WAS A NEW ASSOCIATE PACKAGING THE DEVICE. THERE IS NO EVIDENCE THAT THIS EVENT WAS RELATED TO A DEVICE DEFECT OR MALFUNCTION. HOWEVER, THE INVESTIGATION FOUND THAT THE TRAINING OF A NEW ASSOCIATE FOR THE PROPER POSITIONING OF THE SAMPLING LINE TUBE IN THE PACKAGE HAD BEEN INSUFFICIENT. DUE TO THIS, THE SAMPLING LINE TUBE OF THE ACTUAL DEVICE WAS ACCIDENTALLY SANDWICHED BETWEEN THE DEVICE AND THE CUSHION MATERIAL DURING THE NEW ASSOCIATES PACKAGING WORK, RESULTING IN THE REPORTED DEFORMATION OF THE SAMPLING LINE TUBE. TERUMO MEDICAL PRODUCTS (TMP) (IMPORTER) REGISTRATION NO. 2243441 IS SUBMITTING THIS REPORT ON BEHALF OF ASHITAKA FACTORY OF TERUMO CORPORATION (MANUFACTURER) REGISTRATION NO. 9681834. EXEMPTION NUMBER E2015022.

Description of Event or Problem · 0

THE USER FACILITY REPORTED DURING PREPARATION, THE SAMPLING LINE TUBE WAS FOUND TO HAVE BEEN FLATTENED. THE PROCEDURE OUTCOME AND PATIENT CONDITION WAS UNKNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
237462 CAPIOX FX OXYGENATOR OXYGENATOR, CARDIOPULMONARY BYPASS DTZ TERUMO CORPORATION, ASHITAKA NA 180129

Patients

Seq Age Sex Outcome Treatment
1